1
|
The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale.
|
Clin J Pain
|
2008
|
1.61
|
2
|
Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.
|
J Pain
|
2006
|
1.21
|
3
|
The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome.
|
J Pain
|
2006
|
1.17
|
4
|
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways.
|
J Clin Pharmacol
|
2005
|
0.99
|
5
|
Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.
|
Curr Med Res Opin
|
2004
|
0.95
|
6
|
Frequency of chronic pain descriptors: implications for assessment of pain quality.
|
Eur J Pain
|
2011
|
0.93
|
7
|
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
|
Curr Med Res Opin
|
2004
|
0.91
|
8
|
Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
|
Pain Med
|
2002
|
0.91
|
9
|
Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events.
|
J Pain
|
2011
|
0.91
|
10
|
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?
|
J Pain
|
2006
|
0.90
|
11
|
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
|
Clin Ther
|
2008
|
0.90
|
12
|
The words patients use to describe chronic pain: implications for measuring pain quality.
|
Pain
|
2013
|
0.87
|
13
|
A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.
|
MedGenMed
|
2006
|
0.87
|
14
|
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
|
J Pain
|
2005
|
0.87
|
15
|
Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
|
Curr Med Res Opin
|
2004
|
0.87
|
16
|
More than 7 years of consistent neuropathic pain relief in geriatric patients.
|
Arch Intern Med
|
2003
|
0.85
|
17
|
Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial.
|
Int J Rheum Dis
|
2010
|
0.85
|
18
|
Cognitive testing and revision of the pain quality assessment scale.
|
Clin J Pain
|
2013
|
0.82
|
19
|
The relationship of changes in pain quality to pain interference and sleep quality.
|
J Pain
|
2010
|
0.80
|
20
|
The assessment of pain quality: an item response theory analysis.
|
J Pain
|
2010
|
0.79
|
21
|
The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
|
Clin J Pain
|
2009
|
0.78
|
22
|
The pain quality response profile of pregabalin in the treatment of neuropathic pain.
|
Clin J Pain
|
2012
|
0.77
|
23
|
Effectiveness of lidocaine patch 5% in patients with or without allodynia.
|
CNS Spectr
|
2006
|
0.75
|
24
|
The pain quality response profile of a corticosteroid injections and heated lidocaine/tetracaine patch in the treatment of shoulder impingement syndrome.
|
Clin J Pain
|
2015
|
0.75
|